Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Salmonella Typhimurium O-specific polysaccharide, also known as the O-antigen, is a repeating carbohydrate polymer that constitutes the outermost part of the lipopolysaccharide (LPS) on the bacterial surface. It serves as a major virulence factor by providing a protective barrier that enables the bacterium to evade the host's innate immune system, specifically by conferring resistance to complement-mediated killing and reducing opsonophagocytosis. The structure is characterized by specific repeating units (typically a tetrasaccharide backbone including abequose, mannose, rhamnose, and galactose) that define the serotype identity, such as the O4, O5, and O12 antigens characteristic of serovar Typhimurium. Beyond immune shielding, the O-specific polysaccharide is critical for environmental persistence, biofilm formation, and successful colonization of the host intestinal tract. In therapeutic development, this molecule is a high-priority target for the prevention of salmonellosis and invasive non-typhoidal Salmonella (iNTS) disease. Due to its poor immunogenicity as a standalone T-cell independent antigen, it is frequently conjugated to carrier proteins—such as tetanus toxoid or flagellin—to form conjugate vaccines that elicit robust and long-lasting antibody responses. These vaccines and experimental monoclonal antibodies aim to induce opsonizing and bactericidal antibodies that neutralize the pathogen and facilitate its clearance. Furthermore, the O-antigen serves as the primary receptor for many bacteriophages, making it a central focus for phage-based therapeutic and diagnostic strategies.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Salmonella Typhimurium O-specific polysaccharide (O-Ag).